Braidwell »

Bruker Corporation shares owned by Braidwell

Quarter-by-quarter ownership of Bruker Corporation (BRKR) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Bruker Corporation

Tip: Access up to 7 years of quarterly data

All positions including Bruker Corporation held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bruker Corporation by Braidwell

Quarter filed Position value Share count Share price at filing
2024-12-31 $21M 353k 58.62

More positions owned by Braidwell

Guardant Health Debt 1.250% 2/1 (Principal)
Caris Life Sciences (CAI)
Novocure Note 11/0 (Principal)
Xenon Pharmaceuticals (XENE)
Cg Oncology (CGON)
Neurocrine Biosciences (NBIX)
Repligen Corp Note 1.000%12/1 (Principal)
Krystal Biotech (KRYS)
Nuvalent Inc-a (NUVL)
Neogenomics Note 0.250% 1/1 (Principal)
Soleno Therapeutics (SLNO)
Irhythm Technologies Note 1.500% 9/0 (Principal)
Edgewise Therapeutics (EWTX)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Inspire Med Sys (INSP)

View all positions for Braidwell

Top funds holding Bruker Corporation

Orbis Allan Gray
FMR
BlackRock
Vanguard Group
Pallas Capital Advisors
T. Rowe Price Investment Management
State Street Corporation
Edmond De Rothschild Holding
OZ Management
London Company
Brown Advisory Holdings Incorporated
Vaughan Nelson Investment Management
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley

View all funds holding Bruker Corporation